Arkolith/Insider Trading/TVTX/Form 4

Cline Christopher R.

CHIEF FINANCIAL OFFICERTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$349K
Net Open-Market Flow
-$349K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)1K$42.61$43K117K
Apr 14, 2026Sell(S)9$41.07$370125K
Apr 14, 2026Sell(S)7K$41.93$304K118K
Apr 13, 2026Grant(A)14K—$0125K
Apr 13, 2026Sell(S)65$28.85$2K125K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001943192-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML